Awards/COOPERATIVE AGREEMENT (B)

$139,753,636

Department of Health and Human Services·National Institutes of Health

to DUKE UNIVERSITY

biotechexpiredONGOING · MOD OF 2017 CONTRACT

WORK BEGAN2017-01-01·LATEST ACTION2026-03-20·SOURCEUSASPENDING·SOURCE IDASST_NON_U24TR001608_075

Award description

CENTER FOR INNOVATIVE TRIALS IN CHILDREN AND ADULTS (TRIDENT)

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds Duke University's TRIDENT center to conduct innovative clinical trials in children and adults, a 2017-launched program receiving a 2026 obligation increment.

Sub-sectors

clinical-trialspediatric-researchnih-cooperative-agreement

Why this matters

TRIDENT accelerates pediatric and adult drug development by streamlining trial design and recruitment, reducing time-to-market for new therapeutics and improving evidence for treatment safety and efficacy.

Supply-chain signal

Supports demand for clinical research infrastructure, trial-management software, patient recruitment services, and contract research organizations (CROs) serving academic medical centers.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-24. Cost: $0.002973.

Period of performance

Start

2017-01-01

End

2025-06-30

Status

expired378 days ago

Recipient

DUKE UNIVERSITY

UEI TP7EK8DZV6N5

View full profile →

Other awards from this recipient

See all →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_U24TR001608_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.